Check out

Thursday, January 30, 2025

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

from NYT > Health https://ift.tt/kKBMCEW

No comments:

Post a Comment

New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs

Researchers at the University of Pittsburgh gave transplant recipients certain immune cells from their organ donors. It didn’t always work. ...